• Oral presentation
  • 82

Topical application of inhaled macrophage-specific carbohydrate-coupled antimiR-21 attenuates pulmonary inflammation and fibrosis – two hallmarks of COVID-19.

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
H2

Topics

  • Disease models, drug development
  • Drug transport/delivery and metabolism